108750 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells Cells of the nervous system
Generation of choroid plexus epithelial cells from human embryonic stem cells
#302TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING AMNION DERIVED ADHERENT CELLS
#303Cells useful for immuno-based botulinum toxin serotype A activity assays
#304Exogenous Pax6 nucleic acid expression in primate neural stem cells maintains proliferation without differentiation
#305Cells useful for immuno-based botulinum toxin serotype A activity assays
#306Cells useful for immuno-based botulinum toxin serotype A activity assays
#307Cells useful for immuno-based botulinum toxin serotype A activity assays
#308Cells useful for immuno-based Botulinum toxin serotype A activity assays
#309Stem cell differentiation using novel light-responsive hydrogels
#310Cells useful for immuno-based botulinum toxin serotype A activity assays
#311Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#312Cells useful for immuno-based botulinum toxin serotype A activity assays
#313Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#314DIFFERENTIATION PROCESS OF MESENCHYMAL STEM CELLS AND THERAPEUTIC USE THEREOF
#315Method for inducing differentiation of pluripotent stem cells into neural precursor cells
#316Generation of neural stem cells from human trophoblast stem cells
#317ACCELERATED EXTENSION OF AXONS
#318Culture methods of bone marrow stromal cells and mesenchymal stem cells, and manufacture method of graft cells for central nerve system diseases therapy
#319NEURAL STEM CELL COMPOSITION CAPABLE OF TREATING CANCER AND METHOD OF TREATMENT
#320Method of Diminishing The Symptoms of Neurodegenerative Disease
#321Stem cell differentiating agents and uses therefor
#322THERAPEUTIC ENCAPSULATED EMBRYONIC STEM CELLS AND MESENCHYMAL STROMAL CELLS
#323Polypeptides for Specific Targeting to Otx2 Target Cells
#324Mesenchymal stem cells for the treatment of CNS diseases
#325Neural precursor cells produced from bone marrow stromal cells containing an exogenous nucleic acid encoding a notch intracellular domain (NICD)
#326Culture method of embryoid bodies and/or neural stem cells derived from human differentiated cell-derived pluripotent stem cells
#327Subpopulations of spore-like cells and uses thereof
#328STEM CELLS DERIVED FROM THE CAROTID BODY AND USES THEREOF
#329Differentiation of stem cells into dopaminergic cells
#330Efficient and universal method for neural differentiation of human pluripotent stem cells
#331METHOD FOR SELECTING SECONDARY NEUROSPHERE DERIVED FROM DIFFERENTIATED CELL-DERIVED PLURIPOTENT STEM CELL, CLONE SELECTED BY THE METHOD AND USE OF THE CLONE
#332Ameliorating Nervous Systems Disorders
#333Neural regenerating cells with alterations in DNA methylation
#334Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein
#335Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
#336NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases
#337Peripheral zone tumor cells, methods for their preparation and use
#338CELL CULTURE MEDIA TO DIFFERENTIATE EMBRYONIC STEM CELLS INTO NEURONAL LINEAGES
#339Production of primate neural stem cells through expression of pax6
#340DIRECTED DIFFERENTIATION OF STEM CELLS
#341STEM-LIKE CELLS, METHOD FOR DE-DIFFERENTIATING MAMMALIAN SOMATIC CELLS INTO STEM-LIKE CELLS, AND METHOD FOR DIFFERENTIATING STEM-LIKE CELLS
#342Method for nerve growth and repair using a piezoelectric scaffold
#343Xenotransplant for Stroke Therapy
#344Method of inducing differentiation of bone marrow stromal cells to neural precursor cells, neural precursor cells, and uses thereof
#345Non-human animal model for frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U)
#346Repair and regeneration of ocular tissue using postpartum-derived cells
#347Methods and composition for treating neural degeneration
#348Cells useful for immuno-based Botulinum toxin serotype A activity assays
#349Neural scaffolds
#350Methods for the delivery of toxins or enzymatically active portions thereof
#351Drug screening using islet cells and islet cell progenitors from human embryonic stem cells
#352Bone marrow stromal cells comprising a nucleic acid encoding a notch intracellular domain
#353Trans-Differentiation And Re-Differentiation Of Somatic Cells And Production Of Cells For Cell Therapies
#354TRANSCRIPTION FACTORS FOR DIFFERENTIATION OF ADULT HUMAN OLFACTORY PROGENITOR CELLS
#355Culturing ectodermal cells under reduced oxygen tension
#356Method of Harvesting, Isolating, and Culturing Neural Stem Cells and Related Methods of Treating a Patient
#357NEURAL STEM CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS
#358System and method for controlling G-protein coupled receptor pathways
#359Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
#360Production of Neural Stem Cells from Bone Marrow Tissue and Use Thereof
#361METHOD FOR INDUCING DIFFERENTIATION OF MESODERMAL STEM CELLS, ES CELLS, OR IMMORTALIZED MESODERMAL STEM CELLS INTO NEURAL CELLS
#362Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use
#363Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues
#364Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use
#365XENOTRANSPLANT FOR CNS THERAPY
#366MATERIALS FROM BONE MARROW STROMAL CELLS FOR USE IN FORMING BLOOD VESSELS AND PRODUCING ANGIOGENIC AND TROPHIC FACTORS
#367Neuronal differentiation method of adult stem cells using small molecules
#368Neural progenitor cell populations
#369Islet Cells from Human Embryonic Stem Cells
#370Stem cell differentiating agents and uses therefor
#371Isoxazole amides, derivatives and methods of chemical induction of neurogenesis
#372Compositions and Methods for Enrichment of Neural Stem Cells Using Ceramide Analogs
#373Methods for promoting apoptosis and treating tumor cells inhibiting the expression or function of the transcription factor ATF5
#374Production from blood of cells of neural lineage
#375METHOD OF DIMINISHING THE SYMPTOMS OF NEURODEGENERATIVE DISEASE
#376Homogeneous neural precursor cells
#377Directed Neural Differentiation
#378IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES
#379PANCREATIC STEM CELLS
#380Method of Producing Purified Neural Stem Cells and Related Methods of Treating a Patient
#381Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
#382Neural Cell Differentiation Method From Es Cells
#383Islet Cells from Human Embryonic Stem Cells
#384Method for Preparing Conditioned Medium of Astrocyte-Like Cells
#385De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
#386Neural Stem Cells and Methods of Generating and Utilizing Same
#387Blood brain barrier device
#388Method of deriving pluripotent stem cells from a single blastomere
#389Method for Transdifferentiating Cells
#390Postnatal stem cells and uses thereof
#391Human cord blood as a source of neural tissue repair of the brain and spinal cord
#392Therapeutic uses for mesenchymal stromal cells
#393Blood brain barrier device
#394Choroid plexus device
#395Choroid plexus device
#396Blood brain barrier device
#397Host cells obtained by introducing and expressing VHL gene in cancer cells or embryonic stem cells
#398Methods for regulating differentiation of neural cells and uses thereof
#399Transplantable cell growth niche and related compositions and methods
#400Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
#401Nerve cells obtained by electric pulse treatment of ES cells
#402NOGO-a neutralising immunoglobulin for treatment of neurological diseases
#403Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease
#404Method for production of neuroblasts
#405Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
#406Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
#407Compositions and methods for neural cell production and stabilization
#408Tissue regeneration
#409Method for neural differentiation of embryonic stem cells using protease passaging techniques
#410Differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene
#411Automated tissue engineering system
#412Bioartificial device for propagation of tissue, preparation and uses thereof
#413Compositions and methods for neural differentiation of embryonic stem cells
#414Method of diminishing the symptoms of neurodegenerative disease
#415De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
#416Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5
#417Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
#418Neural progenitor cell populations
#419Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells
#420Endoderm cells from human embryonic stem cells
#421Immunoglobulins which bind NOGO
#422Compositions and methods for enrichment of neural stem cells using ceramide analogs
#423Method for inducing neural differentiation
#424Pancreatic stem cells
#425Xenotransplant for CNS therapy
#426Methods for generating neuronal cells from human embryonic stem cells and uses thereof
#427Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
#428Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
#429Process for producing nerve cells
#430Methods for regulating differentiation of neural cells and uses thereof
#431Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
#432Differentiation of specialized dermal and epidermal cells into neuronal cells
#433Use of cyclic AMP and ascorbic acid to produce dopaminergic neurons from embryonic stem cells
#434Method for the establishment of a pluripotent human blastocyst - derived stem cell line
#435Immortalized mesenchymal cells and utilization thereof
#436Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
#437Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
#438Viscoelastic hydrogel regulation of organoid patterning and vascularization
#439Viscoelastic hydrogel regulation of organoid patterning and vascularization